LBRX vs LCID · $803.4M cap vs rev $687.8M
LB Pharmaceuticals Inc Common Stock (LBRX) versus Lucid Group Inc (LCID) — a side-by-side from cached financials, not a winner call.
LB Pharmaceuticals Inc Common Stock (LBRX) is a biotechnology company listed on NASDAQ.
Lucid Group Inc (LCID) is a auto manufacturers company listed on NASDAQ. It is led by Silvio Napoli.
LBRX does not have a complete income-statement cache yet.
Latest reported LCID revenue for 2026-06-30 was $687.8M. Net income was -$2.06B. LCID currently screens at market cap $2.04B.
LBRX currently screens at market cap $803.4M. LCID currently screens at market cap $2.04B.
Not investment advice. Open the LBRX and LCID stock pages for the full models.
Not investment advice.